IPS22-00005	
    			    			
                SCTCi026-A            
            
        General
Cell Line | 
					|
| hPSCreg name | SCTCi026-A | 
| Cite as: | SCTCi026-A (RRID:CVCL_D6S7) | 
| Alternative name(s) | 
									 
	IPS22-00005	 
							 | 
						
| Cell line type | Human induced pluripotent stem cell (hiPSC) | 
| Similar lines | No similar lines found. | 
| Last update | 11th June 2024 | 
| User feedback | |
Provider | 
					|
| Generator | Radboudumc Stem Cell Technology Center (SCTC) | 
External Databases | 
						|
| BioSamples | SAMEA115712954 | 
| Cellosaurus | CVCL_D6S7 | 
							    
							General Information | 
					|
| Publications | |
| * Is the cell line readily obtainable for third parties? | 
                                     Yes                                                                                 Cell line can only be used in: Only allowed for non-commercial research 
                                                                                    Research use: allowed 
                                                                                    Clinical use: not allowed 
                                                                                    Commercial use: not allowed 
                                                                                    Additional restrictions:  
                                                                        Can be obtained via an MTA  | 
                            
Donor Information
General Donor Information | 
					|
| Sex | female | 
Phenotype and Disease related information (Donor) | 
					|
| Diseases | A disease was diagnosed.
																	 | 
					
External Databases (Donor) | 
						|
| BioSamples | SAMEA115712955 | 
Ethics
| Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? | Yes | 
| Was the consent voluntarily given? | Yes | 
| Has the donor been informed that participation will not directly influence their personal treatment? | Yes | 
| Can you provide us with a copy of the Donor Information Sheet provided to the donor? | Yes | 
| Do you (Depositor/Provider) hold the original Donor Consent Form? | Yes | 
| Confirm that consent was obtained by a qualified professional | Yes | 
| Has the donor agreed to be re-contacted? | Unknown | 
| Has the donor been informed about how her/his data will be protected? | Yes | 
| Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. | pseudonymised | 
| Does consent explicitly allow the derivation of pluripotent stem cells? | Yes | 
| Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? | No | 
Does consent permit research by | |
| an academic institution? | Yes | 
| a public organisation? | No | 
| a non-profit company? | No | 
| a for-profit corporation? | No | 
| How may genetic information associated with the cell line be accessed? | Controlled Access | 
| Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? | No | 
| Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? | Yes | 
| Name of accrediting authority involved? | METC Nijmegen | 
| Approval number | 2021-12051 | 
| For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used? | |
hIPSC Derivation
General | 
						|
| Source cell type | 
										
				
	
	
			 Synonyms 
		
  | 
							
Reprogramming method | 
						|
| Vector type | Non-integrating | 
| Vector | Episomal | 
| Is reprogramming vector detectable? | 
										 No 									 | 
								
| Methods used | 
										 
	PCR	 
									 | 
								
Vector free reprogramming | 
						|
Other | 
						|
| Derived under xeno-free conditions | 
								 Unknown 							 | 
						
| Derived under GMP? | 
								 Unknown 							 | 
						
| Available as clinical grade? | 
								 Unknown 							 | 
						
Culture Conditions
| Surface coating | Matrigel/Geltrex | 
| Feeder cells | 
															 No 														 | 
						
| Passage method | 
								Enzyme-free cell dissociation
								
																											 
											Gentle Cell Dissociation Reagent										 
																	
							 | 
						
| Medium | 
								Essential 8™ Flex		
		
								 | 
						
| Has Rock inhibitor (Y27632) been used at passage previously with this cell line? | No  | 
					
| Has Rock inhibitor (Y27632) been used at cryo previously with this cell line? | No  | 
					
| Has Rock inhibitor (Y27632) been used at thaw previously with this cell line? | Yes  | 
					
Characterisation
Analysis of Undifferentiated Cells
| Marker | Expressed | Immunostaining | RT-PCR | Flow Cytometry | Enzymatic Assay | Expression Profiles | 
| NANOG | 
											 Yes 						                 | 
																                
						                
							                 | 
						                
						                	 | 
						                |||
| POU5F1 (OCT-4) | 
											 Yes 						                 | 
																                
						                
						                	 | 
						                
							                 | 
						                
						                	 | 
						                ||
| SSEA-4 | 
											 Yes 						                 | 
																                
						                
						                	 | 
						                
						                	 | 
						                
							Score: 						
												| Marker | Present | Absent | 
| mCpG | ||
| OCT4 | 
Differentiation Potency
Genotyping
Karyotyping (Cell Line) | 
					|
| Has the cell line karyotype been analysed? | 
								 Yes 								
																	
												Normal karyotype (46, XX)
											 
																				
																															
											Passage number: 24											 
																													 | 
						
Other Genotyping (Cell Line) | 
					|

Login to share your feedback, experiences or results with the research community.